Tue, 21 Sep 2021 11:52:26: Aerie CEO exits days after downplaying midphase eye disease flop

Tue, 21 Sep 2021 10:38:17: BioMed bets $1.2B to ease U.K. life science capacity crunch

Mon, 20 Sep 2021 14:25:49: ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise

Mon, 20 Sep 2021 10:11:15: Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic

Fri, 17 Sep 2021 09:00:50: ESMO: Mirati pulls away from Amgen in colorectal cancer with rival KRAS drug

Fri, 17 Sep 2021 07:52:39: AstraZeneca taps Dana-Farber's Rahma to lead its GI oncology work

Fri, 17 Sep 2021 07:27:59: ESMO: Daiichi unveils first early peek at next-gen ADC as analysts see strong data against rivals

Thu, 16 Sep 2021 15:33:07: New insights into bats' immunity could point to therapeutic approaches for fighting COVID-19

Thu, 16 Sep 2021 15:23:25: ESMO: Novartis links prostate cancer drug to improved pain, quality of life as regulatory filings near

Thu, 16 Sep 2021 12:28:32: ESMO: Zymeworks lays down marker in fight to unseat Herceptin

Thu, 16 Sep 2021 08:44:08: Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it

Wed, 15 Sep 2021 19:12:54: How do faulty genes drive cancer? There's a surprising immune connection, study finds

Wed, 15 Sep 2021 13:58:39: Newly discovered immune cells block melanoma metastasis in mice and could inspire new treatments

Wed, 15 Sep 2021 13:17:06: Abingworth, Gimv and Pfizer back stealthy Swiss startup's $61M round to crack gene therapy delivery

Wed, 15 Sep 2021 12:27:46: Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub

Wed, 15 Sep 2021 12:01:21: Theravance axing 75% of staff, slashing R&D budget after flunking phase 3

Wed, 15 Sep 2021 05:28:37: Moderna, AbCellera join forces to tackle major mRNA opportunity

Tue, 14 Sep 2021 15:36:34: Sanofi dumps Principia Biopharma's San Francisco labs with plans to immediately cut 38 jobs

Tue, 14 Sep 2021 12:40:10: After 3 big exits, Lightstone snags largest fund yet with $375M geared toward next biotechs, medtechs

Tue, 14 Sep 2021 12:38:30: RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients

Tue, 14 Sep 2021 11:54:03: UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout

Tue, 14 Sep 2021 07:37:12: Another death blights Astellas' $3B Audentes buy as FDA slaps clinical hold on the test

Mon, 13 Sep 2021 15:40:24: Kapeller's Rome bags $77M to strike gold in the backwaters of the genome

Mon, 13 Sep 2021 13:37:48: Provention will wait for FDA to 'opine' on new data after teplizumab rejection, eyes Q4 for further talks

Mon, 13 Sep 2021 13:18:20: Attacking Alzheimer's by blocking 'frustrated' amyloid proteins before they form plaques